Header

UZH-Logo

Maintenance Infos

Economic evaluation of caffeine for apnea of prematurity


Dukhovny, D; Lorch, S A; Schmidt, B; Doyle, L W; Kok, J H; Roberts, R S; Kamholz, K L; Wang, N; Mao, W; Zupancic, J A F (2011). Economic evaluation of caffeine for apnea of prematurity. Pediatrics, 127(1):e146-e155.

Abstract

In comparison with placebo, caffeine therapy for apnea of prematurity in infants weighing less than 1250 g is economically appealing for infants up to 18 to 21 months' corrected age.

Abstract

In comparison with placebo, caffeine therapy for apnea of prematurity in infants weighing less than 1250 g is economically appealing for infants up to 18 to 21 months' corrected age.

Statistics

Citations

Dimensions.ai Metrics
16 citations in Web of Science®
25 citations in Scopus®
24 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 20 Jun 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Contributors:Prematurity Trial Group - among others:, Bucher, Hans Ulrich, Fauchère, Jean-Claude
Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neonatology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2011
Deposited On:20 Jun 2011 10:33
Last Modified:17 Feb 2018 13:27
Publisher:American Academy of Pediatrics
ISSN:0031-4005
OA Status:Closed
Publisher DOI:https://doi.org/10.1542/peds.2010-1014
PubMed ID:21173002

Download